ACTRN12622000038796招募中未知
Pharmacogenomics guided antiplatelet selection strategy prior to intracranial or carotid stenting: investigating the impact on platelet aggregation at time of surgery
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patient who are candidates for stenting.
- •Patients who are able to comply with dual antiplatelet therapy
- •Patients are willing to give informed written consent.
- •Patients aged 18 or older will be eligible.
排除标准
- •Contraindications to antiplatelet treatment including but not limited to listed below
- •Acute or ongoing bleeding
- •Thrombocytopenia ie. platelets < 50,000 per microL
- •Severe liver disease as determined by the treating physician
- •Renal Failure eGFR < 30 ml/min/1.73m2
- •Inability to comply with follow up visits.
- •Concurrent requirement for anticoagulation with warfarin or a NOAC
- •TPA use within the last 24 hours
研究者
相似试验
终止
4 期
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) StudyCardiovascular DiseasesAcute Coronary SyndromeNCT01452152University of Maryland, Baltimore9
进行中（未招募）
不适用
Precision PCI RegistryPercutaneous Coronary InterventionCoronary Artery DiseaseNCT06143709University of Florida1,643
终止
4 期
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)ThrombosisCoronary Artery DiseaseNCT01612884Indiana University67
已完成
4 期
Pharmacogenomics of Antiplatelet ResponseAtherosclerosisNCT02234427Johns Hopkins University34
已完成
4 期
Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)Platelet Aggregation InhibitorsCoronary Heart DiseaseNCT00799396University of Maryland, Baltimore682